The Transforming Field of Advanced and Metastatic Breast Cancer Treatment

Kathy D. Miller, MD


July 29, 2022

Kathy D. Miller, MD, reviews the dramatic leaps in therapeutics for advanced and metastatic breast cancer in the context of recalling a specific patient's treatment course. Invoking memory of earlier career experience, Dr Miller describes a scene where, several years after initial diagnosis and untreated with hormone therapy, the patient developed metastatic breast cancer.

The ensuing prescribed treatments of that time involved consequences for the patient that later innovations would mitigate, if not overcome, thus leading Dr Miller to contemplate the vast distances crossed in breast cancer care.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.